It has been shown that the detection of seizures in neonates in the intensive care unit can significantly improve the diagnosis, patient management, and outcome of these patients. At present, this type of monitoring is not done on a routine basis due to technical inadequacies our innovation will overcome. In this Phase II project they will improve the performance of neonatal seizure detection methods developed in Phase I research and implement them to work in real time on a low-cost, easy-to-use bedside monitor. the monitor will developed to the prototype stage and tested in laboratory and clinical settings to prepare for Phase III commercialization. Two corporate partners have been identified for worldwide distribution to neonatal intensive care units. A selection of the neonatal seizures collected as part of this project and background information on neonatal monitoring will be incorporated into an existing interactive CD-ROM based program to provide training for users of the monitor.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
5R42NS033400-03
Application #
2891948
Study Section
Special Emphasis Panel (ZRG1-NEUA (01))
Program Officer
Spinella, Giovanna M
Project Start
1998-06-25
Project End
2000-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Moberg Research, Inc.
Department
Type
DUNS #
City
Ambler
State
PA
Country
United States
Zip Code
19002